SEC Form 4 · accession 0001179110-17-010109
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Andrew H Lane
Officer — Executive Vice President
Period of report
Jun 30, 2017
Accepted (ET)
Jul 5, 2017 · 7:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jun 30, 2017 | F | 0 | $0.00 | D | 0 | D | |
| Common shares without par valueF1 | holding | — | — | — | 0 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of July 5, 2017.